• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A Highly Sensitive and Drug-Tolerant Anti-Drug Antibody Screening Assay for Ixekizumab using Affinity Capture Elution.

作者信息

Muram Talia M, Sloan John H, Chain Jana S, Komocsar Wendy J, Meiklejohn Bruce I, Blauvelt Andrew, Papp Kim, Heffernan Michael P, Qian Yue-Wei, Konrad Robert J

机构信息

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.

出版信息

J Invest Dermatol. 2016 Jul;136(7):1513-1515. doi: 10.1016/j.jid.2016.01.040. Epub 2016 Mar 30.

DOI:10.1016/j.jid.2016.01.040
PMID:27039261
Abstract
摘要

相似文献

1
A Highly Sensitive and Drug-Tolerant Anti-Drug Antibody Screening Assay for Ixekizumab using Affinity Capture Elution.一种使用亲和捕获洗脱法对司库奇尤单抗进行高灵敏度和药物耐受性抗药抗体筛选的检测方法。
J Invest Dermatol. 2016 Jul;136(7):1513-1515. doi: 10.1016/j.jid.2016.01.040. Epub 2016 Mar 30.
2
An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug.一种用于在高药物水平存在的情况下检测针对单克隆抗体治疗药物的抗药抗体的亲和捕获洗脱(ACE)测定法。
J Immunol Methods. 2007 Oct 31;327(1-2):10-7. doi: 10.1016/j.jim.2007.07.004. Epub 2007 Jul 27.
3
An innovative and highly drug-tolerant approach for detecting neutralizing antibodies directed to therapeutic antibodies.一种用于检测针对治疗性抗体的中和抗体的创新且高度耐药物的方法。
Bioanalysis. 2016 Oct;8(20):2157-68. doi: 10.4155/bio-2016-0161. Epub 2016 Sep 5.
4
Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients.对一组接受阿达木单抗治疗的类风湿性关节炎患者进行抗药抗体耐药性检测的系统比较。
J Immunol Methods. 2015 Mar;418:29-38. doi: 10.1016/j.jim.2015.01.007. Epub 2015 Jan 27.
5
Inhibition of interleukin-5 induced false positive anti-drug antibody responses against mepolizumab through the use of a competitive blocking antibody.通过使用竞争性阻断抗体抑制白细胞介素-5诱导的针对美泊利单抗的假阳性抗药物抗体反应。
J Immunol Methods. 2017 Feb;441:15-23. doi: 10.1016/j.jim.2016.11.010. Epub 2016 Nov 24.
6
Nanomolar to sub-picomolar affinity measurements of antibody-antigen interactions and protein multimerizations: fluorescence-assisted high-performance liquid chromatography.纳米摩尔至亚皮摩尔亲和力测量的抗体-抗原相互作用和蛋白质多聚化:荧光辅助高效液相色谱法。
Anal Biochem. 2013 Jun 15;437(2):118-22. doi: 10.1016/j.ab.2013.02.027. Epub 2013 Mar 13.
7
Off-rate screening for selection of high-affinity anti-drug antibodies.筛选抗体解离速率以选择高亲和力的抗药物抗体。
Anal Biochem. 2013 Oct 15;441(2):208-13. doi: 10.1016/j.ab.2013.07.025. Epub 2013 Jul 29.
8
Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.抗白细胞介素-17 单克隆抗体依奇珠单抗治疗慢性斑块状银屑病。
N Engl J Med. 2012 Mar 29;366(13):1190-9. doi: 10.1056/NEJMoa1109997.
9
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.在中度至重度银屑病中比较依奇珠单抗与依那西普或安慰剂的疗效(UNCOVER-2 和 UNCOVER-3):两项 3 期随机临床试验的结果。
Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10.
10
Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation.阿达木单抗在自身免疫性疾病患者中引发有限的抗独特型抗体反应,导致其功能中和。
Ann Rheum Dis. 2013 Jan;72(1):104-9. doi: 10.1136/annrheumdis-2012-201445. Epub 2012 Jul 3.

引用本文的文献

1
Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients.单克隆抗体的免疫原性和 HLA 单倍型预测易患病人群的潜在用途。
Front Immunol. 2022 Jun 17;13:885672. doi: 10.3389/fimmu.2022.885672. eCollection 2022.
2
Immunogenicity of biologic agents in rheumatology.风湿学中的生物制剂的免疫原性。
Nat Rev Rheumatol. 2021 Feb;17(2):81-97. doi: 10.1038/s41584-020-00540-8. Epub 2020 Dec 14.
3
Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials.
依奇珠单抗在斑块状银屑病、银屑病关节炎和中轴型脊柱关节炎成年患者中的安全性:来自 21 项临床试验的数据。
Rheumatology (Oxford). 2020 Dec 1;59(12):3834-3844. doi: 10.1093/rheumatology/keaa189.
4
Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab.评估免疫原性对替拉珠单抗药代动力学、疗效和安全性的影响。
Br J Dermatol. 2020 Jan;182(1):180-189. doi: 10.1111/bjd.17918. Epub 2019 Jul 4.
5
Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis.依奇珠单抗连续给药与间断治疗对比:两项银屑病3期试验的综合分析
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1004-1013. doi: 10.1111/jdv.14163. Epub 2017 Mar 31.